Warberg Asset Management’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
Other funds holding OTLK
Warberg Asset Management's OTLK Position: Q3 2026 in Review
Warberg Asset Management opened a new position in Outlook Therapeutics (OTLK) in Q3 2026: 35,177 shares worth $20.2K. The stake represents ﹤0.01% of the portfolio and ranks #163 among its holdings. This is a return to the name: Warberg Asset Management previously reported a position in OTLK as recently as Q1 2026.
Warberg Asset Management first reported a position in OTLK in Q1 2026 and has held it in 2 quarters since. The position peaked at $56.4K in Q1 2026. 82 funds tracked by Wall St. Rank hold OTLK as of Q3 2026.
- Warberg Asset Management held 35,177 shares of Outlook Therapeutics worth $20.2K as of Q3 2026.
- Outlook Therapeutics was a new Warberg Asset Management position in Q3 2026.
- Outlook Therapeutics made up ﹤0.01% of Warberg Asset Management's portfolio in Q3 2026, its #163 holding.
- Warberg Asset Management first reported a position in Outlook Therapeutics in Q1 2026 and has held it in 2 quarters since.
- Warberg Asset Management's Outlook Therapeutics position peaked at $56.4K in Q1 2026.
- 82 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q3 2026.
Based on Warberg Asset Management's 13F filing for Q3 2026, filed 2 Nov 2026.